PCDHB19P

Across TCGA pan-cancer cohorts, PCDHB19P RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated PCDHB19P data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher PCDHB19P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated PCDHB19P expression acts as an unfavorable survival marker, although some lineages such as HNSC and UCS show a favorable association.

HNSC, UCS, and SKCM are the cancer types where PCDHB19P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Median	III,IV	0.762	0.599	.001	70	view →
UCS	DFS	Median	III,IV	0.437	0.146	.001	52	view →
SKCM	OS	Tertile	IV	0.881	0.488	.005	36	view →
THYM	DFS	Median	II,III,IV	1.000	0.734	.003	27	view →
READ	OS	Median	II,III,IV	0.959	0.407	.007	24	view →
LIHC	OS	Median	III,IV	0.557	0.213	.003	19	view →
OV	DFS	Quartile	All	0.576	0.468	.031	18	view →
PCPG	DFS	Tertile	All	0.690	1.000	.005	16	view →
KIRC	OS	Quartile	All	0.908	0.856	.010	12	view →
ESCA	OS	Median	III,IV	0.722	0.470	.017	12	view →
ACC	DFS	Median	IV	0.495	0.066	.001	11	view →
LUSC	DFS	Quartile	III,IV	0.239	0.552	.009	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

PCDHB19P–HNSC (DFS)

Open the HNSC breakdown →